发明名称 |
Methods of treating a flaviviridae family viral infection, compositions for treating a flaviviridae family viral infection, and screening assays for identifying compositions for treating a flaviviridae family viral infection |
摘要 |
Briefly described, embodiments of this disclosure include compositions, pharmaceutical compositions, methods of treating a host infected with a virus from the Flaviviridae family of viruses, methods of identifying a candidate agent for the treatment of hepatitis C virus (HCV) infection, and the like. |
申请公布号 |
US8895598(B2) |
申请公布日期 |
2014.11.25 |
申请号 |
US200812678014 |
申请日期 |
2008.09.18 |
申请人 |
The Board of Trustees of the Leland Stanford Junior University |
发明人 |
Einav Shirit;Glenn Jeffrey S.;McDowell Robert;Yang Wenjin;Dvory-Sobol Hadas |
分类号 |
A61K31/415;C07K14/005;A61K31/67;A61K31/7056;A61K45/06 |
主分类号 |
A61K31/415 |
代理机构 |
Thomas | Horstemeyer, LLP |
代理人 |
Thomas | Horstemeyer, LLP |
主权项 |
1. A pharmaceutical composition for treating a host having a viral infection for a virus from the Flaviviridae family of viruses, comprising an inhibiting agent, wherein the inhibiting agent has the following structure: |
地址 |
Palo Alto CA US |